TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium November 2, 1984